➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Moodys
Harvard Business School
AstraZeneca
Express Scripts
Merck
Boehringer Ingelheim

Last Updated: July 7, 2020

DrugPatentWatch Database Preview

ALBUTEIN Drug Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Recent Clinical Trials for ALBUTEIN

Identify potential brand extensions & biosimilar entrants

SponsorPhase
Jordi CarratalaPhase 3
Institut d'Investigació Biomèdica de BellvitgePhase 3
Instituto de Salud Carlos IIIPhase 3

See all ALBUTEIN clinical trials

Recent Litigation for ALBUTEIN

Identify key patents and potential future biosimilar entrants

District Court Litigation
Case NameDate
ABRAXIS BIOSCIENCE, LLC v. SUN PHARMA ADVANCED RESEARCH COMPANY, LTD.2019-08-08
Genentech, Inc. v. Pfizer Inc.2019-04-05
Abraxis BioScience, LLC v. HBT Labs, Inc.2018-12-19

See all ALBUTEIN litigation

PTAB Litigation
PetitionerDate
2017-11-09
Cipla Ltd.2017-11-09
Actavis LLC2017-04-04

See all ALBUTEIN litigation

Patent Text Search: US Patents for ALBUTEIN

These patents were identified by searching patent claims

Supplementary Protection Certificates for ALBUTEIN

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C20140031 00119 Estonia   Start Trial PRODUCT NAME: ALBIGLUTIID;REG NO/DATE: K(2014)2052 (LOPLIK) 26.03.2014
300691 Netherlands   Start Trial PRODUCT NAME: ALBIGLUTIDE; REGISTRATION NO/DATE: EU/1/13/908 20140326
563 Finland   Start Trial
91613 Luxembourg   Start Trial 91613, EXPIRES: 20220924
09C0050 France   Start Trial PRODUCT NAME: PACLITAXEL ALBUMINE; REGISTRATION NO/DATE: EU/1/07/428/001 20080111
2009C/046 Belgium   Start Trial PRODUCT NAME: PACLITAXEL ALBUMIN; AUTHORISATION NUMBER AND DATE: EU/1/07/428/001 20080111
>Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts
McKinsey
Johnson and Johnson
McKesson
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.